Literature DB >> 28917250

Emerging technologies in stereotactic body radiotherapy.

Lijun Ma1, Lei Wang2, Chia-Lin Tseng3, Arjun Sahgal3.   

Abstract

Stereotactic body radiation therapy (SBRT) stems from the initial developments of intra-cranial stereotactic radiosurgery (SRS). Despite similarity in their names and clinical goals of delivering a sufficiently high tumoricidal dose, maximal sparing of the surrounding normal tissues and a short treatment course, SBRT technologies have transformed from the early days of body frame-based treatments with X-ray verification to primarily image-guided procedures with cone-beam CT or stereoscopic X-ray systems and non-rigid body immo-bilization. As a result of the incorporation of image-guidance systems and multi-leaf col-limators into mainstream linac systems, and treatment planning systems that have also evolved to allow for routine dose calculations to permit intensity modulated radiotherapy and volumetric modulated arc therapy (VMAT), SBRT has disseminated rapidly in the community to manage many disease sites that include oligometastases, spine lesions, lung, prostate, liver, renal cell, pelvic tumors, and head and neck tumors etc. In this article, we review the physical principles and paradigms that led to the widespread adoption of SBRT practice as well as technical caveats specific to individual SBRT technologies. From the perspective of treatment delivery, we categorically described (I) C-arm linac-based SBRT technologies; (II) robotically manipulated X-band CyberKnife® technology; and (III) emerging specialized systems for SBRT that include integrated MRI-linear accelerators and the imaged-guided Gamma Knife Perfexion Icon system with expanded multi-isocenter treatments of skull-based tumors, head-and-neck and cervical-spine lesions.

Entities:  

Keywords:  Stereotactic body radiation therapy (SBRT); flattening filter free; hypofractionation; robotic; small field

Mesh:

Year:  2017        PMID: 28917250     DOI: 10.21037/cco.2017.06.19

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN: 2304-3865


  9 in total

Review 1.  Why should radiation oncology do translational research? [corrected].

Authors:  Rut Cañas; Isabel Linares; Ferran Guedea; Miguel Ángel Berenguer
Journal:  Rep Pract Oncol Radiother       Date:  2018-11-12

2.  Focused versus conventional radiotherapy in spinal oncology: is there any difference in fusion rates and pseudoarthrosis?

Authors:  Oluwaseun O Akinduro; Gaetano De Biase; Anshit Goyal; Jenna H Meyer; Sukhwinder J S Sandhu; Roman O Kowalchuk; Daniel M Trifiletti; Jason Sheehan; Kenneth W Merrell; Sujay A Vora; Daniel F Broderick; Michelle J Clarke; Mohamad Bydon; Jamal McClendon; Maziyar A Kalani; Alfredo Quiñones-Hinojosa; Kingsley Abode-Iyamah
Journal:  J Neurooncol       Date:  2022-01-07       Impact factor: 4.130

3.  Implications of Radiotherapy Utilization in Korea from 2010 to 2019.

Authors:  Jeongshim Lee; Woo Chul Kim; Won Sup Yoon; Chai Hong Rim
Journal:  J Korean Med Sci       Date:  2021-05-10       Impact factor: 2.153

4.  Verification of rebuild-up effect on superficial cardiac lesion of ventricular tachycardia using 3-D printed phantom in volumetric-modulated arc therapy planning.

Authors:  Shiwon Roh; Jun-Bong Shin; Yong-Ki Bae; Jungmin Kim; Semie Hong; Jeong-Woo Lee
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

Review 5.  Radiotherapy in the Management of Gastrointestinal Stromal Tumors: A Systematic Review.

Authors:  Haidong Zhang; Tianxiang Jiang; Mingchun Mu; Zhou Zhao; Xiaonan Yin; Zhaolun Cai; Bo Zhang; Yuan Yin
Journal:  Cancers (Basel)       Date:  2022-06-28       Impact factor: 6.575

6.  Global status of research on radiotherapy for rectal cancer: A bibliometric and visual analysis.

Authors:  Yafei Xiao; Mengyuan Qiu; Wanting Huang; Shaowen Hu; Cong Tan; Fangmei Nan; Xiaowei Jiang; Dapeng Wu; Mengmeng Li; Quanying Li; Changjiang Qin
Journal:  Front Public Health       Date:  2022-08-08

Review 7.  Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review.

Authors:  Siyer Roohani; Felix Ehret; Marta Kobus; Anne Flörcken; Sven Märdian; Jana Käthe Striefler; Daniel Rau; Robert Öllinger; Armin Jarosch; Volker Budach; David Kaul
Journal:  Radiat Oncol       Date:  2022-09-14       Impact factor: 4.309

Review 8.  Stereotactic Body Radiation Therapy for Spinal Malignancies.

Authors:  Virginia W Osborn; Anna Lee; Yoshiya Yamada
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 9.  Stereotactic radiosurgery for vestibular schwannomas.

Authors:  Steve Braunstein; Lijun Ma
Journal:  Cancer Manag Res       Date:  2018-09-20       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.